Self-testing cholesterol levels for patients after heart attacks
Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
NA · University of Leipzig · NCT06526013
This study tests if heart attack survivors can better manage their cholesterol by checking it themselves every month and sharing the results with their doctors.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Leipzig (other) |
| Locations | 1 site (Leipzig, Saxony) |
| Trial ID | NCT06526013 on ClinicalTrials.gov |
What this trial studies
This study investigates whether patients recovering from acute coronary syndrome can achieve better cholesterol control through self-monitoring of their cholesterol levels. Participants will use a device to measure their cholesterol monthly and report results to their healthcare providers, who will adjust treatment as necessary. The study compares this self-monitoring approach to standard care, which involves less frequent cholesterol checks. The goal is to improve the management of cholesterol levels and reduce the risk of further cardiovascular events.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have experienced acute coronary syndrome within the last six months and have not yet reached their LDL cholesterol target.
Not a fit: Patients who are unable or unwilling to perform self-measurements or adhere to additional cholesterol-lowering therapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better cholesterol management and reduced risk of secondary heart events for patients.
How similar studies have performed: While self-monitoring of health metrics is common, this specific approach to cholesterol management in post-acute coronary syndrome patients is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value * Signed informed consent Exclusion Criteria: * Persons unable to understand the study * Persons unable or unwilling to perform self-measurements * Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target * Pre-menopausal women without contraception * Use of experimental drugs or investigational products within 30 days prior to screening * Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial supporter
Where this trial is running
Leipzig, Saxony
- Clinic of cardiology University clinic Leipzig — Leipzig, Saxony, Germany (RECRUITING)
Study contacts
- Study coordinator: Irina Mueller-Kozarez, Dr.med
- Email: irina.mueller-kozarez@medizin.uni-leipzig.de
- Phone: 03419711732
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Acute Coronary Syndrome, Prevention, LDL Hyperlipoproteinemia, Therapeutic Adherence, Dyslipidemia, Statin, Lipid lowering therapy, Cardiovascular disease